Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer
Jorquera-Cordero, C.; Lara, P.; Cruz, L.J.; Schomann, T.; van Hofslot, A.; de Carvalho, T.G.; Guedes, P.M.D.M.; Creemers, L.; Koning, R.I.; Chan, A.B.; de Araujo Junior, R.F. Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer. Pharmaceutics 2022, 14, 1068. https://doi.org/10.3390/pharmaceutics14051068
Jorquera-Cordero C, Lara P, Cruz LJ, Schomann T, van Hofslot A, de Carvalho TG, Guedes PMDM, Creemers L, Koning RI, Chan AB, de Araujo Junior RF. Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer. Pharmaceutics. 2022; 14(5):1068. https://doi.org/10.3390/pharmaceutics14051068
Chicago/Turabian StyleJorquera-Cordero, Carla, Pablo Lara, Luis J. Cruz, Timo Schomann, Anna van Hofslot, Thaís G. de Carvalho, Paulo M.D.M. Guedes, Laura Creemers, Roman I. Koning, Alan B. Chan, and Raimundo F. de Araujo Junior. 2022. "Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer" Pharmaceutics 14, no. 5: 1068. https://doi.org/10.3390/pharmaceutics14051068